Exploring new pathways in endocrine-resistant breast cancer
The most common breast cancer (BC) subtypes are hormone-dependent, being either estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), or both, and altogether comprise the luminal subtype. The mainstay of treatment for luminal BC is endocrine therapy (ET), which includes several age...
Saved in:
Main Authors: | Inês Soares de Pinho (Author), Catarina Abreu (Author), Inês Gomes (Author), Sandra Casimiro (Author), Teresa Raquel Pacheco (Author), Rita Teixeira de Sousa (Author), Luís Costa (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
by: Jing-Wen Bai, et al.
Published: (2020) -
Endocrine resistant breast cancer: brain metastasis
by: Matthew Willman, et al.
Published: (2022) -
Role of estrogen receptor coregulators in endocrine resistant breast cancer
by: Kristin A. Altwegg, et al.
Published: (2021) -
A Role for Notch Signalling in Breast Cancer and Endocrine Resistance
by: Ahmet Acar, et al.
Published: (2016) -
In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
by: Gary J. Cheng, et al.
Published: (2022)